Pierre-yves Y. Jeandel

Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results.

Berotralstat Tolerability and Effectiveness in Hereditary Angioedema: Berolife Study Results.

Journal: Clinical and translational allergy

Published: December 12, 2025

Relevance of anti-thyroperoxidase antibodies in immune thrombocytopenia in adults: A single-centre cohort study.

Relevance of anti-thyroperoxidase antibodies in immune thrombocytopenia in adults: A single-centre cohort study.

Journal: British journal of haematology

Published: December 05, 2025

Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-France.

Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-France.

Journal: American journal of hematology

Published: March 28, 2025

Large vessel vasculitis without aortitis in giant cell arteritis: About 4 cases

Large vessel vasculitis without aortitis in giant cell arteritis: About 4 cases

Journal: La Revue de medecine interne

Published: March 24, 2025

Diffuse infiltrative lymphocytic syndrome in recently diagnosed HIV patient: a case-report DILS-ILD responsive to steroids.

Diffuse infiltrative lymphocytic syndrome in recently diagnosed HIV patient: a case-report DILS-ILD responsive to steroids.

Journal: Respiratory medicine and research

Published: March 12, 2025

Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab.

Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab.

Journal: RMD open

Published: December 08, 2024

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Journal: American journal of hematology

Published: October 15, 2024

Angioedema Due to Acquired C1-Inhibitor Deficiency Without Hematological Condition: A Multicenter French Cohort Study of 34 Patients.

Angioedema Due to Acquired C1-Inhibitor Deficiency Without Hematological Condition: A Multicenter French Cohort Study of 34 Patients.

Journal: The journal of allergy and clinical immunology. In practice

Published: July 23, 2024

Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.

Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.

Journal: British journal of haematology

Published: July 15, 2023

Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.

Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.

Journal: American journal of hematology

Published: April 19, 2023

Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.

Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.

Journal: The journal of allergy and clinical immunology. In practice

Published: March 30, 2023

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.

Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.

Journal: Blood

Published: March 01, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026